Recursion Pharmaceuticals
RXRX
#3800
Rank
A$4.03 B
Marketcap
$10.04
Share price
6.90%
Change (1 day)
-39.40%
Change (1 year)

Recursion Pharmaceuticals (RXRX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : A$0.65 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's total liabilities are A$0.65 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Recursion Pharmaceuticals - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.66 B138.23%
2023-12-31A$0.27 B-11.81%
2022-12-31A$0.31 B240.57%
2021-12-31A$92.97 M-85.84%
2020-12-31A$0.65 B103.68%
2019-12-31A$0.32 B